
Bioventus BVS
€ 7.78
3.91%
Quartalsbericht 2026-Q1
hinzugefügt 06.05.2026
Bioventus P/B 2011-2026 | BVS
P/B Jährlich Bioventus
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.66 | 3.17 | 1.59 | 0.2 | 0.975 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.17 | 0.2 | 1.72 |
P/B anderer Aktien in der Diagnostik & Forschung
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
Celcuity
CELC
|
53.4 | $ 88.28 | -4.53 % | $ 4.13 B | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 5.63 | -2.26 % | $ 7.49 M | ||
|
Castle Biosciences
CSTL
|
1 | $ 21.01 | -2.73 % | $ 609 M | ||
|
Fulgent Genetics
FLGT
|
0.476 | $ 19.15 | -1.79 % | $ 589 M | ||
|
Aspira Women's Health
AWH
|
0.434 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.181 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
-135 | $ 125.61 | -5.6 % | $ 15.7 B | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 1.67 | -6.7 % | $ 7.39 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
Illumina
ILMN
|
3.8 | $ 162.32 | -3.42 % | $ 25.2 B | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 22.25 | -3.76 % | $ 1.19 B | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
1.1 | $ 149.45 | -2.19 % | $ 11.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 100.98 | -1.79 % | $ 6.82 B | ||
|
Global Cord Blood Corporation
CO
|
0.0622 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
8.08 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
1.77 | $ 10.9 | -3.63 % | $ 1.4 B | ||
|
Natera
NTRA
|
17.8 | $ 215.31 | -3.06 % | $ 29.4 B | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 181.34 | -2.4 % | $ 8.99 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
93.1 | $ 1.45 | -11.04 % | $ 435 M | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 454.25 | -0.97 % | $ 13.1 B | ||
|
Mettler-Toledo International
MTD
|
-1.2 K | $ 1 154.33 | -2.22 % | $ 23.8 B | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 4.57 | -2.56 % | $ 423 M | ||
|
National Research Corporation
NRC
|
22.5 | $ 19.14 | -3.09 % | $ 428 M | ||
|
Personalis
PSNL
|
1.65 | $ 10.75 | -11.16 % | $ 959 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.76 | $ 26.11 | 0.46 % | $ 24.8 B | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 6.67 | -4.85 % | $ 278 M | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
4.63 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
1.75 | $ 2.12 | -1.17 % | $ 4.87 M | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 265.15 | 1.6 % | $ 22.1 B | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | $ 69.22 | -6.37 % | $ 4.14 B | ||
|
Thermo Fisher Scientific
TMO
|
1.78 | $ 472.8 | -1.91 % | $ 178 B | ||
|
Trinity Biotech plc
TRIB
|
-5.51 | $ 0.67 | -2.43 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
7.68 | $ 365.36 | -2.95 % | $ 21.8 B | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 8.9 | -2.41 % | $ 1.93 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 200.29 | 2.13 % | $ 22.2 B |